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The current research was undertaken to determine the potency of two distinct probiotics Biogut® Aqua (feed probiotic) 
and Bioclean® Aqua (water and soil probiotic) to induce immunity and protection faced due to Vibrio pathogen during 
cultivation of Mozambique tilapia under controlled laboratory trials. Assessment was carried out using immune gene 
expression and immunological assays. During the initial phase of treatment, nitro blue tetrazolium (NBT) assay, antiprotease 
assay and peroxidase assay displayed a convincing raise in serum activity of the probiotic managed feed when compared to 
the control groups. In addition, qPCR real time analysis displayed in which nutritional implementation with feed probiotic 
vitally increased the interpretation of immune related genes, particularly TNF and MCP gene expression which are involved 
in immune response. The results revealed that the probiotics Bioclean® Aqua and Biogut® Aqua have beneficial effects 
through efficiently enhancing immune system and protection in tilapia model facing Vibriosis. Hence it can be stated that 
the application of probiotics like Biogut® Aqua and Bioclean® Aqua in aquaculture environment may significantly reduce 
the antibiotic usage, thereby preventing the entry of these chemicals into the food chain. Additionally it was demonstrated 
that the ammonia level in water can be reduced significantly with the application of Bioclean® Aqua (water and soil 
probiotic). The toxicity studies proved that both the probiotic are non-toxic and safe for the use in aquaculture environment. 
[Keywords: Disease resistance, Immune genes, Oreochromis mossambicus, Probiotics] 
Introduction 
Aquaculture refers to the practice of culturing 
animals and plants in water environments. It is also 
referred as aqua farming. Fishes are reared for various 
commercial, domestic and ethical purposes like 
consumption, aesthetics, as model organisms, species 
protection and much more1. Aquaculture has 
developed into a commercial activity drawing 
immense attention across the globe as it provides a 
solution to overfishing wild populations2. Aqua 
farming benefaction to global feed manufacture, 
natural resources for technical and medicinal usage, 
and marine species used in industry has heightened 
perilously in past few years. It has been estimated that 
the worldwide manufacture of marine feed obtained 
from aqua farming for human utilization entered 52.5 
million in 20083. 
Vibrio parahaemolyticus is a rod shaped gram 
negative bacteria which is asporogenous and 
halophilic in nature. It is a pathogen known to infect 
marine organisms like codfish, sardine, crab, lobster, 
crawfish, scallop, oyster and much more. It is found 
to be highly prevalent when the temperature exceeds 
15  and peaks at 25 (ref. 4). The virulence of this 
pathogen is due to the presence of TDH gene which 
encodes thermostable direct haemolysin (TDH) 
protein, a toxin5. V. parahaemolyticus was initially 
recognized after a major outbreak in poisoning of 
food occurred in Osaka, Japan which affected 272 
people killing 20(ref. 6). Since then around 42 outbreaks 
have been documented which spans across the globe. 
In US, around 5000 cases of illnesses are recorded 
because of this V. parahaemolyticus pathogen7. The 
effects observed include gastroenteritis with diarrhea, 
nausea, vomiting, headache, severe abdominal pain 
and low fever. In such cases, the most common 
practice is to use anti-microbial agents to prevent the 
spread of the disease. Although, in current date there 
have been extensive records regarding the emergence 
of antimicrobial resistant pathogens which has forced 
people to explore other methods to control a disease 
outbreak8. The former reason coupled with the 





environmental hazards resulting from the application 
of antibacterial agents has driven the discovery of a 
new class in treatment strategies called probiotics. 
The traditional definition of probiotics says that 
“probiotics are organisms and substances which 
contribute to intestinal microbial balance”. Probiotic 
microorganisms hold the competence to discharge 
chemical matter with antibacterial effect on 
pathogenic bacteria present in the host intestine, 
hence creating an impediment across the 
multiplication of opportunistic pathogens9,10. As in 
mainly, the prophylactic response emanates from the 
ensuing aspects: production of antibiotics, 
bacteriocins, siderophores, and enzymes occasionally 
with the abdominal pH owing to the formation of 
organic acids. 
 Tilapia cultivation is highly advantageous in India 
and is growing day by day. Tilapia has developed into 
the second best prominent seafood after crab, owing 
to which its farming is expanding. However, bacterial 
disease emergence remains a nagging problem in the 
commercial culture of these fishes11,12. This study 
deals with the testing of formulated probiotics against 
V. parahaemolyticus infected tilapia fishes in a 
laboratory setting. There were two probiotics tested, 
one was incorporated into the feed while the other 
was added to the water in which the fishes were 
reared. The probiotic also aimed at reducing the 
ammonia level of the water in which the fishes were 
reared. It has been estimated that ammonia accounts 
for around 40-90 % of nitrogenous excretions. 
Ammonia exists in ionized form and unionized form 
but, only the un-ionized form is toxic to the animals 
being cultured13. At times when the ammonia level 
builds up to a very high degree, it affects the growth 
of the cultured organisms and also results in its 
mortality if not properly controlled14. The current 
analysis was initiated to assess the efficacy of two 
distinct commercially available probiotics, 
Biogut®Aqua (feed probiotic) and Bioclean® Aqua 
(water and soil probiotic) to induce immunity and 
defiance against infection caused due to Vibrio during 
cultivation of Mozambique tilapia under controlled 
laboratory trials. Bioclean® Aqua is a soil and water 
probiotic, highly suitable for use in aquaculture. It 
contains various beneficial species of Bacillus and 
yeasts that are capable of degrading ammonia and 
other toxic waste material accumulated in hatcheries 
and aquaculture ponds over time. This also alleviates 
the onset and increase in pathogen load in the water 
and soil found within aquaculture ponds. 
Biogut®Aqua consists of various beneficial species of 
Bacillus, Lactobacillus and yeast that benefits fish by 
improving their immune response and restricting the 
colonization of pathogenic microbes in the fish gut.  
 
Materials and Methods 
 
Probiotics 
The products evaluated in this study were 
Bioclean® Aqua and Biogut® Aqua (Organica 
Biotech, Mumbai, India). Bioclean® aqua is a soil 
and water probiotic suitable for use in aquaculture. 
Bioclean® Aqua mainly consists of various beneficial 
species of Bacillus and yeast. BioGut® Aqua consists 
of various beneficial species of Bacillus including 
Lactobacillus and yeast. Biogut® Aqua is applied as 
fish feed probiotic that benefits fish by improving 
their immune response and restricting the expansion 
of microbes in the fish gut. The microorganisms 
present in both the formulations were initially 
evaluated for their antimicrobial activity (against a 
variety of fish pathogens including Vibrio sp.), 
enzymatic activity and safety. The cultures were also 
assessed for their compatibility with each other before 
being processed into their respective solid 
formulations. 
 
Estimation of ammonia (NH3) 
Total three groups containing five fishes in a tank 
having 10 L of water were maintained for a week with 
zero water exchange. Group I (Control) having water 
with no treatment, Group II (Bioclean® Aqua I) 
having water mixed with Bioclean® Aqua (5 mg/L) a 
Nessler’S reagent was used to measure free ammonia 
(NH3) level present in the water samples one day post 
immersion. Briefly, 50 mL of water from both the 
groups were taken in a separate beaker and mixed 
with 1 mL of Nessler’s reagent. Components were 
mixed properly and OD was measured after 10 
minutes at 420 nm. The concentration of ammonia 
present in the unknown samples was determined by 
plotting a standard curve by using five different 
concentrations of standard ammonia (0.05 to 0.25 
mg/50 mL)15. 
 
Brine shrimp (Artemia salina) toxicity analysis 
Artemia nauplii model was used for toxicity testing 
of probiotics. Six different concentrations of product 
Bioclean® Aqua ranging from 0 to 80 ppm were 
introduced in a test tube with 5 mL of sea water and 10 




nauplii were introduced in each tube and maintained 
for 24 h to check the mortality. Each concentration was 
tested in triplicates. After 24 hours, survivors were 
counted using 3 X magnifying glasses16. 
 
Tilapia fingerlings bioassay for toxicity analysis 
In this experiment, five different concentrations (10, 
50, 100, 500 and 1000 ppm) of Bioclean® Aqua were 
tested and five tilapia fingerlings were introduced in a 
beaker containing 1 L of water and were maintained for 
one week to check the survival of fishes. Commercial 
fish feed were fed twice a day. Unutilized feed, fecal 
matter and dead fishes were removed before next 
feeding. The water level was maintained throughout 
the experiment with corresponding concentration of 
Bioclean® Aqua product. 
 
Bioassay for ammonia stress induced mortality and qPCR 
gene expression analysis of Corticotropin-releasing hormone 
(CRH) 
Bioassay covered two different groups with five 
fishes in a tank having 10 L of water and was 
maintained for one week with zero water exchange. 
Group I (Control) having water with no treatment and 
Group II having water mixed with Bioclean® Aqua (5 
mg/L). Commercial fish feed was fed to the fish twice 
in a day. Mortalities were observed twice a day 
throughout the experimental period. Brain tissues 
were dissected aseptically for all three groups and 
preserved in RNA later solution for isolation of RNA. 
RNA was isolated utilizing trizol method following 
the manufacturer’s instructions (TaKaRa, Japan). 
cDNA was synthesized from 1 µg of RNA following 
the obtained protocol using the complementary DNA 
Reverse Transcription Kit (TaKaRa, Japan). Relative 
gene expression analysis was done using SYBR® 
Master Mix in Applied Bio systems Step One 
instrument. Ef1-alpha was used as an endogenous 
control and the analysis was performed using 
comparative cycle-threshold (CT) method17. The 
sequence of primers Ef1-alpha and corticotropin-
releasing hormone (CRH) was mentioned in Table 1. 
Primers were synthesized and obtained from Sigma 





Clove oil was employed for anesthetizing fish (0.1 
mL in 1 liter of water) for blood collection without 
sacrificing the fish. Blood was obtained from the gills, 
clotting was performed at 4 ºC followed by 
centrifugation at 10,000 g for 10 min. The serum was 
separated and stored at -80 ºC for further detection 
and quantification of immune assays (antiprotease 




The serum peroxidase assay was analyzed 
following Quade & Roth18. In brief, 5 µl of blood 
serum was reduced employing 45 µl of phenol red-
free Hank’s buffer in 96-well plates. Followed by 
addition of 100 µl of tetramethylbenzidine 
hydrochloride and 5 mM H2O2 were added. The 
change in color of reaction was interrupted after two 
minutes by addition of 50 µl 2 M Sulphuric acid and 
OD was observed at 450 nm. Samples with absence of 
serum were considered as blank. Peroxidase assay 
was calculated as one unit of peroxidase which 
generates an absorbance change of 1 OD. 
 
Antiprotease activity 
Inhibition of trypsin by blood serum was analyzed 
by antiprotease assay19. In brief, 10 µl of trypsin 
procured from sigma was added with 10 µl of serum 
sample solution and incubated for ten minutes at  
22 ºC. Followed by the addition of 100 µl 0.1 M 
phosphate buffer (pH 7.0) and 120 µl of 2 % 
azocasein, further incubation was carried out for 2 h 
at 22 ºC, followed by inclusion of 250 µl of 10 % 
trichloro acetic acid, and incubated for 30 min at  
22 ºC. Centrifugation was carried out at 6,000 g for  
5 min. Briefly 100 µl of supernatant was moved to a 
96-well plate holding 100 µl of 1 N NaOH, the OD 
was recorded at 450 nm employing a plate reader. For 
the positive control, the serum was retrieved by buffer 
while for the negative control; the serum along with 
trypsin was retrieved by buffer.  
 
Table 1 — List of oligonucleotides used for gene expression analysis
Target gene Sequence (5'-3') Size 
(bp)
MCP -Tilapia-F CGG GTT AGC TGT TGG GCA TTG T  198
MCP-Tilapia-R AAG CAA GCA GAG AAA ACC ACT TCA  
EF-1alpha-
Tilapia-F 
CCC AGA AAC ACC GAA ACT AAA 157
EF-1alpha-
Tilapia-R 
TGT CGA TTC CTC CGC ACT   
MyD88-Tilapia-F GGT ATG TTG TGC TGT AGA CTT  
CCG A  
454
MyD88-Tilapia-R GTA GTT CTT TAT TTC CAG GTA GTT G  
TNF-F GCTGGAGGCCAATAAAATCA 339
TNF-R CCTTCCGTCAGTCTCCAGCTC  
LBP-F GGCGCAGCTGGGGAAAGAA 269
LBP-R TGGGGACATCAGTGAGAGGAAGG  
 





Nitric oxide assay 
To determine the amount of nitric oxide generated 
in serum sample we employed the previous protocol20. 
Phosphoric acid (2.5 %), Sulphanilamide (1 %) and 
N-Naphthylethylenediamine (0.1 %) were utilized to 
prepare Griess solution to determine the nitric oxide 
in fish serum samples. About 100 µl of serum sample 
along with the negative control was left for incubation 
with the same volume of Griess solution in a 96 micro 
titer plate and incubation was carried out for 10 
minutes at 27 °C. Following which, OD was read at 
570 nm employing an ELISA reader.  
 
NBT assay  
Nitrobluetetrazolium (NBT) assay was used for 
analyzing the production of superoxide anion 
employing the protocol explained as previous 
article21. Employing 1 ml of syringe, 300 µl of blood 
was drawn and added to a 0.5 ml vial containing 
heparin, to prevent clotting of blood. The heparinized 
blood sample (100 µl) was added in a micro titer plate 
and followed by addition of 100 µl of 0.2 % NBT and 
mixed well. After 30 minutes of incubation at 37 ºC, 
50 µl of Nitrobluetetrazolium-blood suspension was 
mixed to a 1.5 ml vial containing 1 ml of N, N 
dimethyl formamide solution. The vial was subjected 
to centrifugation at 3,000 rpm for 5 minutes and the 
supernatant was obtained. Approximately 200 µl of 
supernatant from each sample was introduced into 
microtiter plate and absorbance was read at 540 nm 
using an ELISA reader. 
 
RNA extraction and immune gene expression analysis  
RNA was obtained from the intestine of the fish on 
completing the feed duration of thirty days. RNA was 
quantified using spectrophotometer. Approximately 1 
µg of RNA was converted to cDNA by reverse 
transcription. PCR was demonstrated employing the 
primers for EF1-α, that was used as an endogenous 
control for the qPCR. The expressions of tumor 
necrosis factor alpha (TNF-α), Lipopolysaccharide 
binding protein (LBP), Mast cell protease (MCP) and 
Myeloid differentiation factor (MYD88) were tested 
employing the primer sequences given in Table 1. 
 
Experimental pathogenicity 
V. parahaemolyticus culture was procured from 
Microbial Type Culture Collection (MTCC-451) and 
purity was accepted following observation with 
biochemical traits as described in Bergy’s standards 
of Bacteriology. The bacterial culture was grown on 
tryptic soya agar and further cultured in Brain heart 
infusion broth to enhance the pathogenicity which 
was used for experimental infection in fish22. Culture 
broth (50 μl) was infected into O. mossambicus intra-
muscularly to determine the infection of Vibrio. The 
lethal dose of the pathogen was found to be 9 × 10−5 
cells/fish. Healthy O. mossambicus were divided into 
four tanks with ten fishes in every group. The 
experiment was carried out in triplicates. Group one 
received phosphate buffer and served as negative 
group. Group 2 fishes were injected with the pathogen 
and served as positive group. Group 3 and 4 were 
treated with Bio clean Aqua and Bio gut Aqua  
(5 mg/L). The experimental fishes were nourished 






Each group containing five fishes in a tank having 
10 L of water and were maintained for a week with 
zero water exchange to check the ammonia level. 
Compared to control after one day post immersion  
of Bioclean® Aqua product with concentration of  
5 mg/L, the ammonia level in water was significantly 
reduced (Fig. 1) 
 
Brine shrimp toxicity analysis 
Brine shrimp toxicity assay is the most favorable 
method for detecting biological properties of different 
compounds. It is used to assess the toxic potential of 
different compounds rapidly with limited requirement 
of the test compounds. The Brine shrimp toxicity 
analysis shows that at 5-10 ppm concentrations of 
Biogut® Aqua and Bioclean® Aqua products were 
nontoxic to the fish (Fig. 2).  
 
Toxicity experiment in Tilapia fingerlings 
The toxicity results indicate that 10 ppm 
concentration of Bioclean® Aqua product were 
 
Fig. 1 — Estimation of ammonia level in water shown a reduction 
after treatment with Bioclean® Aqua 
 




nontoxic and optimal for other biological assay in 
tilapia fish (Fig. 3).  
 
Stress related gene (CRH) expression analysis in Tilapia fish 
Corticotropin-releasing hormone is a hormonal 
peptide and a neurotransmitter responsible for  
stress reaction. The product Bioclean® Aqua have 
mild expression of and up regulated with 0.4 fold 
compared to control and is statistically not significant. 
Hence Bioclean® Aqua is considered better in 
activity in both gene expression and stress response 
analysis (Fig. 4). 
 
Therapeutic experiments 
The fishes treated with probiotics showed a decline 
in mortality as compared to untreated but injected 
with V. parahaemolyticus fishes. A total of 21 out  
of 30 healthy fishes that were injected with  
V. parahaemolyticus, died during the experiment 
tenure giving 70 % mortality. In contrast to this the 
fishes in treated tanks did not show high mortality.  
In treated group Biogut® Aqua, 9 out of 30 fishes 
died with a mortality rate of 30 %, whereas in  
group Bioclean® Aqua I, 6 fishes out of 30 died of 
infection giving a 20 % mortality rate. This could  
be indicative of the effect of probiotic treatment  
that helped fishes in reducing the pathogenic bacterial 
load and thus escaping the infection. The probiotics 
given as water treatment might have a stimulatory 
effect on beneficiary natural microbial population  




Serum of the fish blood was employed to study the 
activity of the peroxidase enzyme described by Quade 
& Roth18. Serum peroxidase activities of Tilapia 
species exposed to V. parahaemolyticus obtained a 
different observation with more decline to a clear 
range in each treatment group (Fig. 5). The 
corresponding serum peroxidase activities three days 
after bacterial infection were consequently higher in 
comparison to the negative group, and then relatively 
reduced after the 3rd day in Biogut® Aqua group. 
Bioclean® Aqua showed a sharp drop in activity and 
then achieved a stable level from 9th day. 
 
Antiprotease activity 
The physiological reaction, stressors and cortisol 
are important immune suppressors. Ability to 
modulate anti-protease activity and subsequently their 
ability to resist bacterial pathogen was clearly visible 
in time course elevation patterns of treated groups 
 
 
Fig. 2 — Brine shrimp toxicity analysis shows nontoxic level




Fig. 3 — Toxicity analysis in Tilapia fingerlings resulting with 10 




Fig. 4 — Stress related gene (CRH) expression analysis in Tilapia 
fish. Bioclean® Aqua shows mild expression and no significant 
changes compare to control group 
 
 





(Fig. 6). Trypsin inhibition was significantly elevated 
after 72 h of infection in the group treated with 
probiotics, in comparison to the time-matched control 
fish. Similarly anti-protease activity went on 
increasing day after day after the probiotic treatment. 
The highest anti-trypsin activity was seen in the 
Bioclean® Aquaon 12th day, when compared to 
Biogut® Aqua. The lowest activity was observed in 
the Biogut® Aqua at the 3rd day. 
 
Nitric oxide activity 
At the 3rd day post infection, nitric oxide 
concentration in serum samples were elevated, then 
relatively reduced on 6th day. An increase in nitric 
oxide activity on 9th day, Biogut® Aqua was 
observed. Bioclean® Aqua was consistent with 
constant decline in level from 3rd to 12th day. The 
reduction in NO concentration was highly significant 
at 12th day in Biogut® Aqua treatment group. 
Negative control group value was less than those of 
Positive control as expected (Fig. 7). 
 
NBT assay 
NBT is a reagent that can absorb superoxide and 
change its color to purple (absorbed at 540 nm). NBT 
assay in blood serum of fish defined to Biogut® Aqua 
and Bioclean® Aqua probiotic treatment was 
compared to that of control group (Fig. 8). Serum 
activity of fish in treatment group employing 
probiotics was comparatively greater when compared 
to the respective positive group value at each point of 
time. Time course elevation pattern among the treated 
groups indicates that the probiotic fed group induced 
elevation of NBT activity was at peak value on 9th day 
of post infection. Prior to 9th day, the NBT activity 
 
 
Fig. 5 — Serum peroxidase activity in serum of Mozambique




Fig. 6 — Antiprotease activity in serum of Mozambique Tilapia
treated with Biogut® Aqua and Bioclean® Aqua 
 
 
Fig. 7 — Nitric oxide activity in serum of Mozambique Tilapia 
treated with Biogut® Aqua and Bioclean® Aqua 
 
 
Fig. 8 — Nitroblue tetrazolium assay in serum of Mozambique 
Tilapia treated with Biogut® Aqua and Bioclean® Aqua 
 




showed an increase and after that the activity 
declined.  
 
Gene expression analysis 
mRNA expression of LBP seems to be increasing 
with increase in duration of time. It displays its 
function immunity particularly during response in 
acute phase (Fig S1). From the obtained results we 
infer that Bioclean® Aqua treatment seems to be 
efficient in decreasing the inflammation. The 
expression of this gene is been regulated well in this 
method of treatment than the control. This treatment 
seems to be better among other group. TNF is a 
cytokine responsible for systemic inflammation and is 
involved in acute phase response. From the mRNA 
expression analysis it is disclosed that during initial 
phase of treatment with Bioclean® Aqua the TNF-
alpha level is increased in its regulation and at the end 
of the treatment course it resolves to normal 
suggesting that TNF-alpha efficiently inhibits the 
pathogenesis (Fig. S2). MCP has varied roles such as 
inflammatory and anti-inflammatory tissue 
homeostasis and innate immunity, its deregulated 
release contribute to the pathogenesis to a number of 
inflammatory conditions. Again Bioclean® Aqua and 
its treatment method seem to be under regulation 
because it is increased during the initial phase of 
infection and regulated at the end of treatment course 
(Fig. 9). Myeloid differentiation factor is a universal 
adapter protein which activates transcription factor 
NF kappa B. It shows resistance to common viral and 
bacterial infections. The expression of this gene has 
been increased during the initial phase and has been 
regulated well by Bioclean® Aqua at the end of the 
course (Fig. S3). 
 
Cumulative mortality assay 
The signs and symptoms of infection generally 
appear having inactivity and anorexia. Discoloration, 
redness and necrosis occur on the outer layer of the 
fish as the infection is progressed in the positive 
control. Blood filled blemishes appear over the mouth 
and fin. Boil-like sores appeared on the body, the skin 
surface resulted in large, open sores. The fishes 
commenced to display mortality and signs of infection 
following injection with V. parahaemolyticus. 
Anomalous behavior and deficit activity were 
visualized in the positive group. Fall in appetite and 
abrasions were found on the surface of the skin. 
Absence of infectious signs was recorded in the 
negative group injected with PBS. Bioclean Aqua and 
Biogut Aqua were employed for protection and 
defense of bacterial infection in O. mossambicus. A 
100 % survival was recorded in both Bioclean and 
Biogut Aqua (5 mg/L) with mild clinical symptoms 
similar to positive group. Group 3 and Group 4 that 
remained as treated groups were checked for 30 days 
post infection and it declined to bring mortality. 
Cumulative mortality results are depicted in  
Figure 10. Mortality was absent in negative control 
receiving PBS buffer. 
 
Discussion 
Probiotics have shown an excellent ability to resist 
disease and prevent pathogens. Probiotic 
supplementation results in improvements in microvilli 
density and length, which can increase the absorptive 
surface of the fish intestines and ultimately enhance 
the host’s physical barrier against potential pathogens. 
Probiotics have an essential part which stimulates the 
immune response in fish. In the current analysis, 
tilapia treated with feed probiotics showed significant 
increase in non-specific immune response, which 
includes respiratory bursts, antiprotease, serum 
peroxidase and nitric oxide assay at initiative stage of 
 
Fig. 9 — Gene expression analysis of Mast cell protease encoding
gene in three different time durations 
 
 
Fig. 10 — Cumulative mortality of groups treated with Bioclean 
and Biogut Aqua (5mg/L) 
 





treatment and reduced at the deadline of treatment 
course. Nitric oxide has varied significance in 
immune response acting as lethal agent against 
pathogenic organisms. The activity employing NBT 
decline to identify oxidative radical generation in the 
process of phagocytosis is a potentimmune response 
and is broadly employed to detect protection against 
infectious microbes23-25. Dietary supplementation of 
Biogut® Aqua has notably enhanced the survival of 
Tilapia fed diets. Gene expression analysis reveals 
that regulation of immune genes are increased during 
the initial stage and well regulated by probiotic 
treated group at the end of the treatment course 
suggesting the inhibition of pathogenesis which 
indicates Bio clean aqua has better efficiency than 
Biogut aqua. Various analyses have identified the 
valuable properties of probiotics on the development 
in growth of tilapia. Antibacterial assays were 
persuaded by Probiotics against Vibrio 
parahaemolyticus in this study. Probiotic treated 
group showed 85 % of survival whereas bacterial 
infected group showed only 20 % of survival 
following in vivo treatment. A related inhibitory assay 
for Bacillus subtilis and Bacillus S11 culture were 
determined formerly. Similar antibacterial assay could 
be associated to the certainty that the bacillus can be 
aroused to challenge with different rapid expanding 
microbes for nourishment26. It’s widely understood 
that probiotics are living microbial supplement giving 
beneficial effects in developing the progress, survival 
and overall well-being of the commercially cultivated 
organisms use good framing27. Probiotics are 
employed to treat diseases essentially due to their 
activity in immune system and anti-inflammatory 
response. Probiotics used in our study showed 
reduction in expression of pro inflammatory cytokine. 
In completion, the current study shows the early 
approach to assess the outcome of immersion and 
nutritional consumption of probiotic bacteria on 
disease resistance and innate status of tilapia fish. The 
data added support about the possible usage of 
probiotics, as an interesting immunostimulant for 
farmed fish. Our study validates that applicable forms 
of Biogut Aqua and Bioclean® Aqua, which was 
Biogut is feed probiotic and Bioclean is for water and 
soil application, adequately improved Mozambique 
tilapia immunity and apparently increased 65 % 
survival and disease resistance against bacterial 
infection in lab experiments, which could be further 
implemented in field levels. 
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